O. A. Andreev, A. G. Karabadzhak, D. Weerakkody, G. O. Andreev, D. M. Engelman et al., pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path, Proceedings of the National Academy of Sciences, vol.107, issue.9, pp.4081-4086, 2010.
DOI : 10.1073/pnas.0914330107

L. A. Arantes, C. J. Aguiar, M. J. Amaya, N. C. Figueiro, L. M. Andrade et al., Nuclear inositol 1,4,5-trisphosphate is a necessary and conserved signal for the induction of both pathological and physiological cardiomyocyte hypertrophy, Journal of Molecular and Cellular Cardiology, vol.53, issue.4, 2012.
DOI : 10.1016/j.yjmcc.2012.06.017

D. J. Behm, J. J. Mcatee, J. W. Dodson, M. J. Neeb, H. E. Fries et al., Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues, British Journal of Pharmacology, vol.46, issue.Suppl 1, 2008.
DOI : 10.1038/bjp.2008.266

A. Bignami, R. Asher, and G. Perides, Brain Extracellular Matrix and Nerve Regeneration, Adv. Exp. Med. Biol, vol.296, pp.197-206, 1991.
DOI : 10.1007/978-1-4684-8047-4_19

B. Boivin, D. Chevalier, L. R. Villeneuve, E. Rousseau, A. et al., Functional Endothelin Receptors Are Present on Nuclei in Cardiac Ventricular Myocytes, Journal of Biological Chemistry, vol.278, issue.31, pp.29153-29163, 2003.
DOI : 10.1074/jbc.M301738200

B. Boivin, C. Lavoie, G. Vaniotis, A. Baragli, L. R. Villeneuve et al., Functional ??-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes, Cardiovascular Research, vol.71, issue.1, pp.69-78, 2006.
DOI : 10.1016/j.cardiores.2006.03.015

B. Boivin, G. Vaniotis, B. G. Allen, H. , and T. E. , G Protein-Coupled Receptors in and on the Cell Nucleus: A New Signaling Paradigm?, Journal of Receptors and Signal Transduction, vol.6, issue.103, pp.15-28, 2008.
DOI : 10.1093/annonc/mdh136

M. D. Bootman, C. Fearnley, I. Smyrnias, F. Macdonald, R. et al., An update on nuclear calcium signalling, Journal of Cell Science, vol.122, issue.14, pp.2337-2350, 2009.
DOI : 10.1242/jcs.028100

A. Brkovic, A. Hattenberger, E. Kostenis, T. Klabunde, S. Flohr et al., Functional and Binding Characterizations of Urotensin II-Related Peptides in Human and Rat Urotensin II-Receptor Assay, Journal of Pharmacology and Experimental Therapeutics, vol.306, issue.3, 2003.
DOI : 10.1124/jpet.103.052415

A. Carotenuto, P. Grieco, P. Campiglia, E. Novellino, R. et al., Unraveling the Active Conformation of Urotensin II, Journal of Medicinal Chemistry, vol.47, issue.7, pp.1652-1661, 2004.
DOI : 10.1021/jm0309912

H. Castel, M. Diallo, D. Chatenet, J. Leprince, L. Desrues et al., Biochemical and functional characterization of high-affinity urotensin???II receptors in rat cortical astrocytes, Journal of Neurochemistry, vol.22, issue.2, pp.582-595, 2006.
DOI : 10.1111/j.1471-4159.2006.04130.x

D. Chatenet, Q. T. Nguyen, M. Letourneau, N. D. Doan, J. Dupuis et al., Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation, British Journal of Pharmacology, vol.26, issue.4, 2012.
DOI : 10.1111/j.1476-5381.2012.02217.x
URL : https://hal.archives-ouvertes.fr/pasteur-00819041

D. Chatenet, Q. T. Nguyen, M. Letourneau, J. Dupuis, and A. Fournier, Urocontrin, a novel UT receptor ligand with a unique pharmacological profile, Biochemical Pharmacology, vol.83, issue.5, pp.608-615, 2012.
DOI : 10.1016/j.bcp.2011.12.009
URL : https://hal.archives-ouvertes.fr/pasteur-01001676

A. Christopoulos and T. Kenakin, G Protein-Coupled Receptor Allosterism and Complexing, Pharmacological Reviews, vol.54, issue.2, 2002.
DOI : 10.1124/pr.54.2.323

M. Clozel, C. Binkert, M. Birker-robaczewska, C. Boukhadra, S. S. Ding et al., Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System, Journal of Pharmacology and Experimental Therapeutics, vol.311, issue.1, 2004.
DOI : 10.1124/jpet.104.068320

M. Clozel, P. Hess, C. Qiu, S. S. Ding, R. et al., The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats, Journal of Pharmacology and Experimental Therapeutics, vol.316, issue.3, pp.1115-1121, 2006.
DOI : 10.1124/jpet.105.094821

J. M. Conlon, F. O-'harte, D. D. Smith, M. C. Tonon, and H. Vaudry, Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda, Biochemical and Biophysical Research Communications, vol.188, issue.2, pp.578-583, 1992.
DOI : 10.1016/0006-291X(92)91095-8

Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint et al., Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord, Proc. Natl, 1998.
DOI : 10.1073/pnas.95.26.15803

H. Y. Dai, W. Q. Kang, X. Wang, X. J. Yu, Z. H. Li et al., The involvement of transforming growth factor-??1 secretion in Urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts, Regulatory Peptides, vol.140, issue.1-2, pp.88-93, 2007.
DOI : 10.1016/j.regpep.2006.11.015

D. Mello and W. C. , Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications for myocardial ischaemia, Journal of the renin-angiotensin-aldosterone system : JRAAS, vol.9, issue.2, pp.112-118, 2008.
DOI : 10.3317/jraas.2008.014

M. Diallo, H. Castel, M. Jarry, L. Desrues, T. Lefebvre et al., Urotensin II and urotensin II-related peptide regulate normal astrocyte activity. Potential involvement in glioma proliferation, Neuron Glia Biol, vol.3, p.161, 2007.

N. D. Doan, T. T. Nguyen, M. Letourneau, K. Turcotte, A. Fournier et al., Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart, British Journal of Pharmacology, vol.6, issue.1, pp.243-257, 2012.
DOI : 10.1111/j.1476-5381.2011.01710.x
URL : https://hal.archives-ouvertes.fr/pasteur-00818552

S. A. Douglas, D. J. Ashton, C. F. Sauermelch, R. W. Coatney, D. H. Ohlstein et al., Human Urotensin-II is a Potent Vasoactive Peptide, Journal of Cardiovascular Pharmacology, vol.36, issue.Supplement 1, pp.163-166, 2000.
DOI : 10.1097/00005344-200036051-00051

S. A. Douglas and E. H. Ohlstein, Human Urotensin-II, the Most Potent Mammalian Vasoconstrictor Identified To Date, as a Therapeutic Target for the Management of Cardiovascular Disease, Trends in Cardiovascular Medicine, vol.10, issue.6, pp.229-237, 2000.
DOI : 10.1016/S1050-1738(00)00069-4

C. Dubessy, D. Cartier, B. Lectez, C. Bucharles, N. Chartrel et al., Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction, Journal of Neurochemistry, vol.42, issue.2, 2008.
DOI : 10.1111/j.1471-4159.2008.05624.x

E. Duverger, C. Pellerin-mendes, R. Mayer, A. C. Roche, and M. Monsigny, Nuclear import of glycoconjugates is distinct from the classical NLS pathway, J. Cell Sci, vol.108, pp.1325-1332, 1995.

P. Eggena, J. H. Zhu, K. Clegg, and J. D. Barrett, Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA, Hypertension, vol.22, issue.4, 1993.
DOI : 10.1161/01.HYP.22.4.496

A. P. Fontes-sousa, A. L. Pires, V. F. Monteiro-cardoso, and A. F. Leite-moreira, Urotensin II-induced increase in myocardial distensibility is modulated by angiotensin II and endothelin-1, Physiol. Res, vol.58, pp.653-660, 2009.

A. Gibson, Complex effects of Gillichthys urotensin II on rat aortic strips, British Journal of Pharmacology, vol.105, issue.suppl. 1, pp.205-212, 1987.
DOI : 10.1111/j.1476-5381.1987.tb09000.x

D. Guidolin, G. Albertin, R. , and D. , Urotensin-II as an angiogenic factor, Peptides, vol.31, issue.6, pp.1219-1224, 2010.
DOI : 10.1016/j.peptides.2010.03.022

A. C. Hanyaloglu, V. Zastrow, and M. , Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications, Annual Review of Pharmacology and Toxicology, vol.48, issue.1, 2008.
DOI : 10.1146/annurev.pharmtox.48.113006.094830

C. L. Herold, D. J. Behm, P. T. Buckley, J. J. Foley, W. E. Wixted et al., The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors, British Journal of Pharmacology, vol.508, issue.2, pp.203-207, 2003.
DOI : 10.1038/sj.bjp.0705251

C. Hillier, C. Berry, M. C. Petrie, P. J. O-'dwyer, C. Hamilton et al., Effects of Urotensin II in Human Arteries and Veins of Varying Caliber, Circulation, vol.103, issue.10, pp.1378-1381, 2001.
DOI : 10.1161/01.CIR.103.10.1378

T. Hirose, K. Takahashi, N. Mori, T. Nakayama, M. Kikuya et al., Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: Comparison with endothelin-1, Peptides, vol.30, issue.6, pp.1124-1129, 2009.
DOI : 10.1016/j.peptides.2009.02.009

S. G. Hood, A. M. Watson, M. , and C. N. , Cardiac actions of central but not peripheral urotensin II are prevented by ??-adrenoceptor blockade, Peptides, vol.26, issue.7, pp.1248-1256, 2005.
DOI : 10.1016/j.peptides.2005.01.005

M. Jarry, M. Diallo, C. Lecointre, L. Desrues, T. Tokay et al., The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation, Biochemical Journal, vol.451, issue.1, pp.113-124, 2010.
DOI : 10.1016/j.atherosclerosis.2005.10.044
URL : https://hal.archives-ouvertes.fr/hal-00479207

X. Jiang, J. L. Benovic, and P. B. Wedegaertner, Plasma Membrane and Nuclear Localization of G Protein-coupled Receptor Kinase 6A, Molecular Biology of the Cell, vol.18, issue.8, pp.2960-2969, 2007.
DOI : 10.1091/mbc.E07-01-0013

Y. J. Jong, V. Kumar, A. E. Kingston, C. Romano, O. Malley et al., Functional Metabotropic Glutamate Receptors on Nuclei from Brain and Primary Cultured Striatal Neurons: ROLE OF TRANSPORTERS IN DELIVERING LIGAND, Journal of Biological Chemistry, vol.280, issue.34, pp.30469-30480, 2005.
DOI : 10.1074/jbc.M501775200

T. Kenakin, New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism, Nature Reviews Drug Discovery, vol.220, issue.11, pp.919-927, 2005.
DOI : 10.1089/1540658041850607

T. Kenakin, Functional Selectivity in GPCR Modulator Screening, Combinatorial Chemistry & High Throughput Screening, vol.11, issue.5, pp.337-343, 2008.
DOI : 10.2174/138620708784534824

T. Kenakin, Functional Selectivity and Biased Receptor Signaling, Journal of Pharmacology and Experimental Therapeutics, vol.336, issue.2, pp.296-302, 2011.
DOI : 10.1124/jpet.110.173948

T. Kenakin and L. J. Miller, Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery, Pharmacological Reviews, vol.62, issue.2, pp.265-304, 2010.
DOI : 10.1124/pr.108.000992

P. Keov, P. M. Sexton, C. , and A. , Allosteric modulation of G protein-coupled receptors: A pharmacological perspective, Neuropharmacology, vol.60, issue.1, pp.24-35, 2011.
DOI : 10.1016/j.neuropharm.2010.07.010

T. A. Kohout, S. L. Nicholas, S. J. Perry, G. Reinhart, S. Junger et al., Differential Desensitization, Receptor Phosphorylation, ??-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7, Journal of Biological Chemistry, vol.279, issue.22, pp.23214-23222, 2004.
DOI : 10.1074/jbc.M402125200

H. Krum and W. Kemp, Therapeutic potential of blockade of the Urotensin II system in systemic hypertension, Current Hypertension Reports, vol.41, issue.1, pp.53-58, 2007.
DOI : 10.1007/s11906-007-0010-x

K. Leach, P. M. Sexton, C. , and A. , Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology, Trends in Pharmacological Sciences, vol.28, issue.8, pp.382-389, 2007.
DOI : 10.1016/j.tips.2007.06.004

D. K. Lee, A. J. Lanca, R. Cheng, T. Nguyen, X. D. Ji et al., Agonist-independent Nuclear Localization of the Apelin, Angiotensin AT1, and Bradykinin B2 Receptors, Journal of Biological Chemistry, vol.279, issue.9, pp.7901-7908, 2004.
DOI : 10.1074/jbc.M306377200

M. A. Lee-kirsch, F. Gaudet, M. C. Cardoso, and K. Lindpaintner, Distinct Renin Isoforms Generated by Tissue-Specific Transcription Initiation and Alternative Splicing, Circulation Research, vol.84, issue.2, pp.240-246, 1999.
DOI : 10.1161/01.RES.84.2.240

Q. Liu, S. S. Pong, Z. Zeng, Q. Zhang, A. D. Howard et al., Identification of Urotensin II as the Endogenous Ligand for the Orphan G-Protein-Coupled Receptor GPR14, Biochemical and Biophysical Research Communications, vol.266, issue.1, pp.174-178, 1999.
DOI : 10.1006/bbrc.1999.1796

J. J. Maguire and A. P. Davenport, Is urotensin-II the new endothelin?, British Journal of Pharmacology, vol.508, issue.Suppl. II, pp.579-588, 2002.
DOI : 10.1038/sj.bjp.0704924

J. J. Maguire, R. E. Kuc, and A. P. Davenport, Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1, British Journal of Pharmacology, vol.332, issue.(in press), pp.441-446, 2000.
DOI : 10.1038/sj.bjp.0703601

A. Marchese, M. Heiber, T. Nguyen, H. H. Heng, V. R. Saldivia et al., Cloning and Chromosomal Mapping of Three Novel Genes, GPR9, GPR10, and GPR14, Encoding Receptors Related to Interleukin 8, Neuropeptide Y, and Somatostatin Receptors, Genomics, vol.29, issue.2, pp.335-344, 1995.
DOI : 10.1006/geno.1995.9996

B. E. Maryanoff and W. A. Kinney, Urotensin-II Receptor Modulators as Potential Drugs, Journal of Medicinal Chemistry, vol.53, issue.7, pp.2695-2708, 2010.
DOI : 10.1021/jm901294u

L. T. May, K. Leach, P. M. Sexton, C. , and A. , Allosteric Modulation of G Protein???Coupled Receptors, Annual Review of Pharmacology and Toxicology, vol.47, issue.1, pp.1-51, 2007.
DOI : 10.1146/annurev.pharmtox.47.120505.105159

M. Mori, T. Sugo, M. Abe, Y. Shimomura, M. Kurihara et al., Urotensin II Is the Endogenous Ligand of a G-Protein-Coupled Orphan Receptor, SENR (GPR14), Biochemical and Biophysical Research Communications, vol.265, issue.1, pp.123-129, 1999.
DOI : 10.1006/bbrc.1999.1640

T. T. Nguyen, M. Letourneau, D. Chatenet, and A. Fournier, Presence of urotensin-II receptors at the cell nucleus: Specific tissue distribution and hypoxia-induced modulation, The International Journal of Biochemistry & Cell Biology, vol.44, issue.4, 2012.
DOI : 10.1016/j.biocel.2011.12.022
URL : https://hal.archives-ouvertes.fr/pasteur-00817600

H. P. Nothacker, Z. Wang, A. M. Mcneill, Y. Saito, S. Merten et al., Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction, Nat. Cell Biol, vol.1, pp.383-385, 1999.

T. Ono, Y. Kawaguchi, M. Kudo, T. Kushikata, E. Hashiba et al., Urotensin II evokes neurotransmitter release from rat cerebrocortical slices, Neuroscience Letters, vol.440, issue.3, pp.275-279, 2008.
DOI : 10.1016/j.neulet.2008.05.096

P. Papadopoulos, N. Bousette, and A. Giaid, Urotensin-II and cardiovascular remodeling, Peptides, vol.29, issue.5, pp.764-769, 2008.
DOI : 10.1016/j.peptides.2007.09.012

C. B. Patel, N. Noor, and H. A. Rockman, Functional Selectivity in Adrenergic and Angiotensin Signaling Systems, Molecular Pharmacology, vol.78, issue.6, pp.983-992, 2010.
DOI : 10.1124/mol.110.067066

H. C. Prosser, M. E. Forster, A. M. Richards, and C. J. Pemberton, Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury, Peptides, vol.29, issue.5, pp.770-777, 2008.
DOI : 10.1016/j.peptides.2007.08.013

C. D. Proulx, B. J. Holleran, P. Lavigne, E. Escher, G. Guillemette et al., Biological properties and functional determinants of the urotensin II receptor, Peptides, vol.29, issue.5, pp.691-699, 2008.
DOI : 10.1016/j.peptides.2007.10.027

R. Re, The Nature of Intracrine Peptide Hormone Action, Hypertension, vol.34, issue.4, pp.534-538, 1999.
DOI : 10.1161/01.HYP.34.4.534

R. N. Re, A proposal regarding the biology of memory: participation of intracrine peptide networks, Medical Hypotheses, vol.63, issue.5, pp.887-894, 2004.
DOI : 10.1016/j.mehy.2004.04.027

B. F. Roettger, D. Ghanekar, R. Rao, C. Toledo, J. Yingling et al., Antagonist-stimulated internalization of the G proteincoupled cholecystokinin receptor, Mol. Pharmacol, vol.51, pp.357-362, 1997.

C. Rondanino, M. T. Bousser, M. Monsigny, and A. C. Roche, Sugar-dependent nuclear import of glycosylated proteins in living cells, Glycobiology, vol.13, issue.7, pp.509-519, 2003.
DOI : 10.1093/glycob/cwg064

R. Roskoski and . Jr, ERK1/2 MAP kinases: Structure, function, and regulation, Pharmacological Research, vol.66, issue.2, pp.105-143, 2012.
DOI : 10.1016/j.phrs.2012.04.005

B. Ross, K. Mckendy, and A. Giaid, Role of urotensin II in health and disease, AJP: Regulatory, Integrative and Comparative Physiology, vol.298, issue.5, pp.1156-1172, 2010.
DOI : 10.1152/ajpregu.00706.2009

Y. Shiraishi, T. Watanabe, T. Suguro, M. Nagashima, R. Kato et al., Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice, Journal of Hypertension, vol.26, issue.10, pp.1955-1965, 2008.
DOI : 10.1097/HJH.0b013e32830b61d8

R. A. Silvestre, E. M. Egido, R. Hernandez, J. Leprince, D. Chatenet et al., Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas, European Journal of Endocrinology, vol.151, issue.6, pp.803-809, 2004.
DOI : 10.1530/eje.0.1510803

W. Song, A. E. Abdel-razik, W. Lu, Z. Ao, D. G. Johns et al., Urotensin II and renal function in the rat, Kidney International, vol.69, issue.8, pp.1360-1368, 2006.
DOI : 10.1038/sj.ki.5000290

A. Sorkin, V. Zastrow, and M. , Endocytosis and signalling: intertwining molecular networks, Nature Reviews Molecular Cell Biology, vol.13, issue.9, pp.609-622, 2009.
DOI : 10.1016/j.tips.2007.09.001
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895425

R. Spinazzi, G. Albertin, B. Nico, D. Guidolin, D. Liddo et al., Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro, International Journal of Molecular Medicine, 2006.
DOI : 10.3892/ijmm.18.6.1107

A. Stirrat, M. Gallagher, S. A. Douglas, E. H. Ohlstein, C. Berry et al., Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries, Am. J. Physiol. Heart Circ. Physiol, vol.280, pp.925-928, 2001.

T. Sugo, Y. Murakami, Y. Shimomura, M. Harada, M. Abe et al., Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain, Biochemical and Biophysical Research Communications, vol.310, issue.3, pp.860-868, 2003.
DOI : 10.1016/j.bbrc.2003.09.102

A. Tadevosyan, G. Vaniotis, B. G. Allen, T. E. Hebert, and S. Nattel, G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function, The Journal of Physiology, vol.84, issue.6, pp.1313-1330, 2012.
DOI : 10.1113/jphysiol.2011.222794

M. Tal, D. A. Ammar, M. Karpuj, V. Krizhanovsky, M. Naim et al., A Novel Putative Neuropeptide Receptor Expressed in Neural Tissue, Including Sensory Epithelia, Biochemical and Biophysical Research Communications, vol.209, issue.2, pp.752-759, 1995.
DOI : 10.1006/bbrc.1995.1563

S. Terrillon and M. Bouvier, Receptor activity-independent recruitment of ??arrestin2 reveals specific signalling modes, The EMBO Journal, vol.19, issue.20, pp.3950-3961, 2004.
DOI : 10.1126/science.1073308

G. Vaniotis, D. Duca, D. Trieu, P. Rohlicek, C. V. Hebert et al., Nuclear ??-adrenergic receptors modulate gene expression in adult rat heart, Cellular Signalling, vol.23, issue.1, pp.89-98, 2011.
DOI : 10.1016/j.cellsig.2010.08.007

A. M. Watson, G. W. Lambert, K. J. Smith, M. , and C. N. , Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic Actions, Hypertension, vol.42, issue.3, pp.373-379, 2003.
DOI : 10.1161/01.HYP.0000084633.85427.E6

D. Xu, G. R. Borges, J. L. Grobe, C. J. Pelham, B. Yang et al., Preservation of Intracellular Renin Expression Is Insufficient to Compensate for Genetic Loss of Secreted Renin, Hypertension, vol.54, issue.6, pp.1240-1247, 2009.
DOI : 10.1161/HYPERTENSIONAHA.109.138677

T. Yoshimoto, M. Matsushita, and Y. Hirata, Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor, Peptides, vol.25, issue.10, pp.1775-1781, 2004.
DOI : 10.1016/j.peptides.2004.03.028

Y. G. Zhang, J. Li, Y. G. Li, W. , and R. H. , Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta, Journal of Hypertension, vol.26, issue.6, pp.1119-1126, 2008.
DOI : 10.1097/HJH.0b013e3282fa1412